Kathmandu, January 10

Department of Drug Administration has recalled 22 kinds of medicine manufactured by Nepali and Indian pharmaceutical companies after they were found substandard.

The department has advised all against purchase, sale and use of the medicines. While some of the medicines failed dissolution and endotoxin tests, others didn’t have the required bacterial and microbial count. “We recall medicines if they are found substandard,” said Narayan Prasad Dhakal, director general at DoDA.

Acitop (M260L015), Rapeed 20 (RBT 3021), Metro 400 (MTT 0317), Indosafe (081002), Laxo 100 G (151), Laxo 300 G (152), Panopaz IV (NI 6701), Glipide (GP-30), Glipride 2 (LPN 72148) have been recalled. Similarly, Prasarnashak Churna (14-A), Ahatavaryadi Churna (12-B) and Lavan Bhaskar Churna (9), among others, have also been recalled.